Translucent Polypropylene Phenylephrine Bags for Oxidation Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing phenylephrine formulations in large volume containers are unstable due to oxidation and photolytic degradation, requiring opaque bags that hinder impurity detection and have short shelf life, necessitating multiple vials for infusion and undesirable excipients.
Innovation Solution
Use of translucent polypropylene bags with controlled oxygen transmission rates to stabilize phenylephrine solutions, eliminating stabilizing excipients like sulfites and sodium hydroxide, and maintaining transparency for impurity detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If opaque bags are used to protect phenylephrine from light degradation, then photolytic stability is improved, but the ability to detect impurities and discoloration is lost
Solution Approach 1:
The patent introduces an intermediary substance (vitamin C/ascorbic acid) that acts as a sacrificial antioxidant to protect phenylephrine from oxidation. This mediator absorbs the oxidative stress that would otherwise degrade phenylephrine, allowing the bag to remain transparent while maintaining stability. The vitamin C oxidizes preferentially, creating a protective chemical environment without requiring opaque packaging.
2Duration of action of stationary object
If small glass vials are used to maintain chemical stability, then shelf life is improved, but the need for reconstitution and multiple vials for infusion increases complexity
Solution Approach 1:
The patent changes the concentration parameter of phenylephrine in the formulation, using a lower concentration (0.05-2 mg/mL) that allows direct IV infusion without reconstitution. This parameter change enables the use of larger volume containers (50-500 mL) while maintaining stability through the combined effect of lower concentration and vitamin C protection, eliminating the need for vial reconstitution and simplifying the administration process.
3Stability of the object's composition
If stabilizing excipients like sulfites and sodium hydroxide are added to ensure stability, then chemical stability is improved, but the formulation complexity and potential adverse effects increase
Solution Approach 1:
The patent extracts or removes the need for traditional stabilizing excipients like sulfites and sodium hydroxide by replacing them with vitamin C as a safer, more compatible stabilizer. This extraction of harmful or complex excipients simplifies the formulation while maintaining stability through the antioxidant properties of vitamin C, which is generally recognized as safe and causes fewer adverse effects.
4Difficulty of detecting and measuring
If translucent bags are used to enable impurity detection, then visibility is improved, but photolytic degradation increases
Solution Approach 1:
The patent uses vitamin C as a chemical intermediary that absorbs the harmful effects of light exposure and oxygen, protecting phenylephrine from photolytic and oxidative degradation. This allows the use of translucent bags that enable visual inspection of the solution for impurities and discoloration, while the vitamin C mediator prevents light-induced degradation that would otherwise occur in transparent packaging.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The phenylephrine solutions remain stable over time, allowing for single-use transparent bags that maintain transparency for impurity detection and extend shelf life without additional excipients.
Implementation Method 1
it is believed that translucent polypropylene inhibits the passage of light having a wavelength that destabilizes the phenylephrine
Implementation Method 2
even when polypropylene is used having only moderate blockage of oxygen transmission
Data Source
AI summary
Ready to use semi-naked dilute solutions of phenylephrine, resistant to oxidative degradation when packaged in transparent or translucent collapsible polypropylene bags and terminally sterilized, without the need for an aluminum over-wrap, oxygen scavengers, oxygen impermeable polypropylene, antioxidants, or chelating agents.